Organogenesis Holdings (ORGO) Enterprise Value (2015 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Enterprise Value of -$92.1 million for Q1 2026, up 16.68% year-over-year from -$78.9 million in Q1 2025, and up 2.37% quarter-over-quarter from -$94.3 million in Q4 2025.
Organogenesis Holdings (ORGO) Enterprise Value (2015 - 2026) Analysis & Trends
Organogenesis Holdings' Enterprise Value history runs 12 years deep, the most recent figure standing at -$92.1 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 16.68% year-over-year to -$92.1 million; the TTM figure through Mar 2026 stood at -$92.1 million (up 16.68% YoY), while the FY2025 annual figure was -$94.3 million, up 30.72% from the prior year.
- Enterprise Value for Q1 2026 stood at -$92.1 million, up from -$94.3 million in the prior quarter.
- The five-year high for Enterprise Value was -$64.4 million in Q3 2025, with the low at -$136.2 million in Q4 2024.
- The 5-year median for Enterprise Value is -$94.9 million (2024), against an average of -$97.7 million.
- The sharpest annual moves came in 2022 and 2025: Enterprise Value plunged 22080.9% in 2022, then soared 32.19% in 2025.
- Organogenesis Holdings' Enterprise Value stood at -$103.3 million in 2022, then declined by 1.01% to -$104.3 million in 2023, then tumbled by 30.49% to -$136.2 million in 2024, then jumped by 30.72% to -$94.3 million in 2025, then rose by 2.37% to -$92.1 million in 2026.
- Business Quant data shows ORGO's Enterprise Value at -$92.1 million in Q1 2026, -$94.3 million in Q4 2025, and -$64.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn | -46.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -46.84 Mn |
| Mar 31, 2026 | -92.10 Mn |
| Dec 31, 2025 | -94.33 Mn |
| Sep 30, 2025 | -64.37 Mn |
| Jun 30, 2025 | -73.74 Mn |
| Mar 31, 2025 | -110.53 Mn |
| Dec 31, 2024 | -136.15 Mn |
| Sep 30, 2024 | -94.93 Mn |
| Jun 30, 2024 | -90.48 Mn |
| Mar 31, 2024 | -89.35 Mn |
| Dec 31, 2023 | -104.34 Mn |
| Sep 30, 2023 | -98.83 Mn |
| Jun 30, 2023 | -89.51 Mn |
| Mar 31, 2023 | -89.42 Mn |
| Dec 31, 2022 | -103.29 Mn |
| Sep 30, 2022 | -108.02 Mn |
| Jun 30, 2022 | -112.94 Mn |
| Mar 31, 2022 | -108.50 Mn |
| Dec 31, 2021 | -114.53 Mn |
| Sep 30, 2021 | -487,000.00 |